Back to results
US 2025/0084250 A1Published application
Azaindole cyanine dyes, uses, and methods of preparation
AssigneeLife Technologies Corporation
InventorsYi-Zhen HU, Brian EVANS
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to new and useful azaindole cyanine (pyrrolo pyridine cyanine) compounds. Use of the compounds as dyes that operate in the far-red and near-IR spectral region in biological imaging, and methods of making the compounds are also disclosed herein. The azaindole cyanine (pyrrolo pyridine cyanine) compounds have formulas (I) and (II).
Claims40
A compound chosen from Formula (I) or Formula (II):
- wherein
- A is C or N;
- n is 0, 1, or 2;
- each of R1, R2, R3, and R4 is the same or different and is independently chosen from alkyl, heteroalkyl, sulfoalkyl group, alkyl with terminal -Su (succinimidyl/sulfosuccinimidyl) ester, heteroalkyl with terminal —SO3, and alkyl with terminal (Q)zC(O)OR*, and heteroalkyl with terminal (Q)zC(O)OR*,
- where Q is a 5 or 6 membered aryl or heteroaryl ring, z is 0, 1, 2, or 3, R* is chosen from —H, —(CH2)ySO3, and N-hydroxysuccinimide, and y is 1, 2, 3, 4, or 5;
- each of R5, R6, R11, and R12 is the same or different and is independently chosen from —SO3, -lower alkylene-QR13, -Q(CH2)zR13, -(Q′)y(R13)z, and -Q″(R13),
- where Q′ is chosen from thiophene, furan, and pyrrole rings, Q″ is a dithienothiophene, and R13 is chosen from —H, —SO3, —COOH;
- R7 is —H or SO3;
- R8 is chosen from —H, alkyl, and La-Z;
- or alternatively, R7 is SRr, and R8 is alkyl, wherein Rr is an alkylene that forms an unsaturated ring with R8;
- R9 is chosen from —H, alkyl, sulfoalkyl, La-Z, and La-X, on the condition that R8 and R9 are not both —H;
- and
- R10 is chosen from alkyl, sulfoalkyl, La-Z, and La-X,
- where La is selected from the group consisting of a divalent linear (—(CH2)o—, o=0 to 15), crossed, or cyclic alkane group that can be substituted by at least one atom selected from substituted nitrogen and/or sulfur;
- where L is selected from the group consisting of a divalent linear (—(CH2)o—, o=0 to 15), crossed, or cyclic alkane group that can be substituted by at least one atom selected from the group consisting of oxygen, substituted nitrogen, and/or sulfur;
- where Z is selected from the group consisting of H, CH3, alkyl, heteroalkyl, NH2, —COO−, —COOH, —COSH, CO—NH—NH2, —COF, —COCl, —COBr, —COI, —COO-Su (succinimidyl/sulfosuccinimidyl) ester, —COO-STP (4-sulfo-2,3,5,6-tetrafluorophenyl), —COO-TFP (2,3,5,6-tetrafluorophenyl), —COO-benzotriazole, —CO-benzotriazole, —CONR′—CO—CH2—I, —CONR′R″, —CONR′-biomolecule, —CONR′-L-COO—, —CONR′-L-COOH, —CONR′-L-COO-Su, —CONR′-L-COO-STP, —CONR′-L-COO-TFP, —CONR′-L-CONR″2, —CONR′-L-CO-biomolecule, —CONR′-L-CO—NH—NH2, —CONR′-L-OH, —CONR′-L-CHO, —CONR′-L-maleimide, and —CONR′-L-NH—CO—CH2—I;
- R′ and R″ is selected from the group consisting of H, alkyl group, and heteroalkyl group, and the biomolecule is a protein, antibody, nucleotide, oligonucleotide, biotin, or hapten;
- X is selected from the group consisting of —SH, —NH2, —NH—NH2, —F, —Cl, —Br, I, —NHS (hydroxysuccinimidyl/sulfosuccinimidyl) ester, —O-TFP (2,3,5,6-tetrafluorophenoxy), —O-STP (4-sulfo-2,3,5,6-tetrafluorophenoxy), —O-benzotriazole, -benzotriazole, —NR-L-OH, —NR-L-SH, —NR-L-NH2, —NR-L-NH—NH2, —NR-L-CO2H, —NR-L-CO—NHS, —NR-L-CO-STP, —NR-L-CO-TFP, —NR-L-CO-benzotriazole, —NR-L-CHO, —NR-L-maleimide, and —NR-L-NH—CO—CH2—I, where R is —H or an alkyl or heteroalkyl group;
- and
- with the proviso that the compound of Formula (II) cannot be chosen from:
17 more elements
A compound of Table A.
Dependencies are inferred from the claim text.